ResMed Inc (RMD)

Return on total capital

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 1,687,855 1,597,084 1,553,975 1,470,187 1,370,185 1,289,140 1,215,227 1,164,511 1,144,441 1,113,601 1,047,195 1,007,300 1,000,286 986,526 975,687 957,365 912,348 892,002 886,076 844,659
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 5,967,860 5,546,130 5,253,010 5,195,030 4,864,040 4,629,920 4,481,850 4,250,380 4,129,900 3,932,510 3,738,130 3,432,890 3,360,750 3,278,800 3,145,840 3,026,050 2,885,680 2,709,230 2,864,980 2,678,860
Return on total capital 28.28% 28.80% 29.58% 28.30% 28.17% 27.84% 27.11% 27.40% 27.71% 28.32% 28.01% 29.34% 29.76% 30.09% 31.02% 31.64% 31.62% 32.92% 30.93% 31.53%

June 30, 2025 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $1,687,855K ÷ ($—K + $5,967,860K)
= 28.28%

The analysis of ResMed Inc.'s return on total capital over the specified period reveals a generally stable profitability trend with slight fluctuations. Beginning at approximately 31.53% as of September 30, 2020, the metric experienced a gradual decline over the subsequent quarters, reaching a low of around 27.11% by December 31, 2023. This decline indicates a reduction in the company's efficiency in generating earnings relative to its total capital base over this timeframe.

However, starting from early 2024, a modest recovery is observed, with the return rising to approximately 29.58% by the end of December 2024. In 2025, the return fluctuated slightly but remained relatively stable, ending at around 28.28% as of June 30, 2025. These recent movements suggest a stabilization in the company's ability to leverage its total capital effectively, despite a prior downward trend.

Overall, the period reflects a slight but sustained decrease in return on total capital from its initial high levels, with periods of recovery indicating potential improvements in operational efficiency or capital management. The data suggests that while the company maintained a relatively consistent level of profitability concerning its total capital, there is an ongoing need to examine underlying factors influencing these performance shifts.